Ignite Creation Date:
2024-05-06 @ 10:56 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03388359
Status:
UNKNOWN
Last Update Posted:
2020-09-07
First Post:
2017-08-23
Brief Title:
Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma
Sponsor:
Lithuanian University of Health Sciences
Organization:
Lithuanian University of Health Sciences
Study Overview
Official Title:
Role of Extracellular Matrix in the Development of Airway Remodeling in Asthma
Status:
UNKNOWN
Status Verified Date:
2020-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ECMA
Brief Summary:
Asthma is a major noncommunicable chronic inflammatory disorder which is characterized by airway inflammation and related to pathological modifications of the bronchial wall structure so called airway remodeling Airway remodeling seen in asthma is mainly described by epithelial changes subepithelial fibrosis increased airway smooth muscle ASM mass decreased distance between ASM and epithelium mucous gland and goblet cell hyperplasia vascular changes and edema Near these well known pathophysiological changes of the airways the extracellular matrix ECM can be distinguished as a new important factor included in development of airway remodeling in asthma
Detailed Description:
Asthma is a major noncommunicable chronic inflammatory disorder which is characterized by airway inflammation and related to pathological modifications of the bronchial wall structure so called airway remodeling Airway remodeling seen in asthma is mainly described by epithelial changes subepithelial fibrosis increased airway smooth muscle ASM mass decreased distance between ASM and epithelium mucous gland and goblet cell hyperplasia vascular changes and edema Near these well known pathophysiological changes of the airways the extracellular matrix ECM can be distinguished as a new important factor included in development of airway remodeling in asthma
ECM is a building block between airways and lung parenchyma It plays a crucial role in the maintenance of pulmonary structure and functions influencing the distribution and adhesion of inflammatory cells fluid balance elasticity and can act as a resource of inflammatory mediators In asthma predominant eosinophilic airway inflammation can result the dysregulation of ECM which are identified as altered quantitative and qualitative composition of ECM activated molecular signaling pathways which are responsible for triggered ECM proteins production The main sources of ECM proteins in lungs are pulmonary fibroblasts and ASM cells In asthma fibroblasts are responsive to many inflammatory cytokines which activate and promote fibroblasts proliferation contractility and cellular differentiation to myofibroblasts form with up-regulated rate of matrix production In turn activated fibroblasts secrete cytokines IL-1β IL-33 CXC CC chemokines various types of matrix metalloproteinases MMPs as well as reactive oxygen species These factors allow fibroblasts to assist in the activation and migration of resident immune cells and endow fibroblast roles in chemical and cell-mediated immunity acute and chronic inflammation extravasation of immune cells into connective tissue of the lungs The ASM cells are also the strong contributor to the ECM protein pool in the lungs - they can produce the variety of ECM proteins contributing to the tissue structure and elasticity which are seen unbalanced in asthma While fibroblasts and ASM cells determine ECM proteins composition the ECM in turn can affect the structural cells behavior in lung tissue The role of cell-matrix interactions represents an area for active investigation on the ability of lung matrix to prime the structural pulmonary cells
The excess of ECM proteins deposition is associated with activation of profibrotic factor transforming growth factor-beta 1 TGF-β1 mediated WNT and Smad signaling pathways Highest levels of TGF-β1 in airways are released by eosinophils - the main inflammatory cells in asthma pathogenesis During stable asthma and especially allergen provoced acute asthma episodes eosinophils infiltrate into the airways enhancing local levels of TGF-β1 and other various cytokines chemokines and growth factors near the connective tissue and ASM bundles However how eosinophil-released mediators induce ECM dysregulation leading to development of airway remodeling are not investigated part of asthma pathogenesis
Asthma still cannot be cured but appropriate management can control the disease severity Better understanding in development of asthma is the main objective which must to be pursued Based on this rationale the investigators aimed to investigate eosinophilic airway inflammation mediated production of ECM proteins and MMPs activity for their release responsible molecular signaling pathways and how dysregulated ECM affect fibroblasts and ASM cells proliferation migration differentiation and contractility in asthma Trying to understand and control the development of asthma the investigators will use models of combined cells cultures estimating ECM homeostasis in stable and acute asthma Blocking with specific inhibitors of WNT and Smad signaling pathways potentially responsible for ECM proteins and MMPs production will help to find the controlling mechanisms of ECM dysregulation Therefore evaluation of ECM proteins degradation fragments and levels of MMPs will help to estimate an applied value of these circulating biomarkers in asthma patients
ECM is a building block between airways and lung parenchyma It plays a crucial role in the maintenance of pulmonary structure and functions influencing the distribution and adhesion of inflammatory cells fluid balance elasticity and can act as a resource of inflammatory mediators In asthma predominant eosinophilic airway inflammation can result the dysregulation of ECM which are identified as altered quantitative and qualitative composition of ECM activated molecular signaling pathways which are responsible for triggered ECM proteins production The main sources of ECM proteins in lungs are pulmonary fibroblasts and ASM cells In asthma fibroblasts are responsive to many inflammatory cytokines which activate and promote fibroblasts proliferation contractility and cellular differentiation to myofibroblasts form with up-regulated rate of matrix production In turn activated fibroblasts secrete cytokines IL-1β IL-33 CXC CC chemokines various types of matrix metalloproteinases MMPs as well as reactive oxygen species These factors allow fibroblasts to assist in the activation and migration of resident immune cells and endow fibroblast roles in chemical and cell-mediated immunity acute and chronic inflammation extravasation of immune cells into connective tissue of the lungs The ASM cells are also the strong contributor to the ECM protein pool in the lungs - they can produce the variety of ECM proteins contributing to the tissue structure and elasticity which are seen unbalanced in asthma While fibroblasts and ASM cells determine ECM proteins composition the ECM in turn can affect the structural cells behavior in lung tissue The role of cell-matrix interactions represents an area for active investigation on the ability of lung matrix to prime the structural pulmonary cells
The excess of ECM proteins deposition is associated with activation of profibrotic factor transforming growth factor-beta 1 TGF-β1 mediated WNT and Smad signaling pathways Highest levels of TGF-β1 in airways are released by eosinophils - the main inflammatory cells in asthma pathogenesis During stable asthma and especially allergen provoced acute asthma episodes eosinophils infiltrate into the airways enhancing local levels of TGF-β1 and other various cytokines chemokines and growth factors near the connective tissue and ASM bundles However how eosinophil-released mediators induce ECM dysregulation leading to development of airway remodeling are not investigated part of asthma pathogenesis
Asthma still cannot be cured but appropriate management can control the disease severity Better understanding in development of asthma is the main objective which must to be pursued Based on this rationale the investigators aimed to investigate eosinophilic airway inflammation mediated production of ECM proteins and MMPs activity for their release responsible molecular signaling pathways and how dysregulated ECM affect fibroblasts and ASM cells proliferation migration differentiation and contractility in asthma Trying to understand and control the development of asthma the investigators will use models of combined cells cultures estimating ECM homeostasis in stable and acute asthma Blocking with specific inhibitors of WNT and Smad signaling pathways potentially responsible for ECM proteins and MMPs production will help to find the controlling mechanisms of ECM dysregulation Therefore evaluation of ECM proteins degradation fragments and levels of MMPs will help to estimate an applied value of these circulating biomarkers in asthma patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| PSUL-0102014 | OTHER | Lithuanian University of Health Sciences | None |